Your search history is turned on.
Date: March 1, 2021 Jurisdictions: Alberta, British Columbia, Ontario
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Dr. Hai Shiene Chen, Chief Executive Officer of ACGT DNA Technologies Corp. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of ACGT DNA Technologies Corp. (the issuer) for the interim ...
1 Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate I, Glen Macdonald, Chief Financial Officer of ACGT DNA Technologies Corp. certify the following: 1. Review: I have reviewed the interim financial report and interim MD&A (together, the interim filings) of ACGT DNA Technologies Corp. (the issuer) for the interim period en...
Microsoft Word - ACGT - MDA Q3 2021 V3.docx Form 51-102F1 ACGT DNA TECHNOLOGIES CORPORATION MANAGEMENTS DISCUSSION AND ANALYSIS For the Three and Nine Months Ended December 31, 2020 Background The following discussion and analysis, prepared as of March 1, 2021, should be read together with the unaudited condensed interim consolidat...
2020 12 31 ACGT Corporation0000002WCWUF.cvw Condensed Interim Consolidated Financial Statements ACGT DNA Technologies Corporation Stated in Canadian Dollars For the Three and Nine Month Periods Ended December 31, 2020 and 2019 Unaudited INDEX Condensed Interim Consolidated Statements of Financial Position 1 Condensed Interim Consolidated Statements o...
Date: December 3, 2020 Jurisdictions: Alberta, British Columbia, Ontario
form_13-502f2 with penalty.pdf FORM 13-502F2 CLASS 2 REPORTING ISSUERS PARTICIPATION FEE MANAGEMENT CERTIFICATION I, _______________________, an officer of the reporting issuer noted below have examined this Form 13-502F2 (the Form) being submitted hereunder to the Ontario Securities Commission and certify that to my knowledge, having exercised reasonabl...
Date: November 30, 2020 Jurisdictions: Alberta, British Columbia, Ontario
Microsoft Word - ACGT - MDA Q2 2021 V2.docx Form 51-102F1 ACGT DNA TECHNOLOGIES CORPORATION MANAGEMENTS DISCUSSION AND ANALYSIS For the Three and Six Months Ended September 30, 2020 Background The following discussion and analysis, prepared as of November 30, 2020, should be read together with the unaudited condensed interim consol...
2020 09 30 ACGT Corporation0000002WCWUF.cvw Condensed Interim Consolidated Financial Statements ACGT DNA Technologies Corporation Stated in Canadian Dollars For the Three and Six Month Period Ended September 30, 2020 and 2019 Unaudited INDEX Condensed Interim Consolidated Statements of Financial Position 1 Condensed Interim Consolidated Statements of...
Date: November 27, 2020 Jurisdictions: Alberta, British Columbia, Ontario